Partial
Mostly Aligned
Patient Risk:
Low
Summary
The AI response correctly states the indication (ED and BPH), identifies tadalafil as the active ingredient, and confirms available strengths (5 mg and 20 mg). It, however, makes several claims about patent status and generic availability that are not supported by the label, resulting in partial alignment.
Category Scores
Accurate Statements
Cialis is a medication used to treat erectile dysfunction and benign prostatic hyperplasia.
1.3 Indications and Usage - Erectile Dysfunction; Benign Prostatic Hyperplasia (BPH)
Tadalafil is the active ingredient in Cialis.
11 Description - Active ingredient: tadalafil
Cialis (tadalafil) is available in 5 mg and 20 mg dosage forms.
3 Dosage Forms and Strengths - 5 mg and 20 mg
Unsupported Statements
The primary patents for Cialis, as well as its exclusivity, have expired in major markets like the United States and Europe.
Not present in the supplied label.
This patent expiry has paved the way for the availability of generic tadalafil.
Not present in the supplied label.
Main patents related to Cialis have expired, allowing for generic competition.
Not present in the supplied label.
Following the patent expiry of brand-name Cialis, generic tadalafil became available.
Not present in the supplied label.
Generic tadalafil is available.
Not present in the supplied label.
Generic versions of tadalafil are available and are typically less expensive than the brand-name drug.
Not present in the supplied label.
Contradictions
Important Omissions
The label lists 10 mg as one of the strengths; the claim mentions only 5 mg and 20 mg (omits 10 mg).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Claims evaluated pertain to indication and ingredient; no safety or dosing risk identified in the evaluated statements.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Unauthorized patent/generic status claims
Suggested Improvement
Limit claims to indications, active ingredient, and available strengths as per label; remove or clearly qualify statements about patents and generic availability that are not in the label; ensure strength coverage aligns exactly with the label (include 10 mg if claimed).